Skip to main content

Peer Review reports

From: Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset

Original Submission
18 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
14 Nov 2022 Reviewed Reviewer Report
19 Dec 2022 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 4
19 Dec 2022 Submitted Manuscript version 4
21 Dec 2022 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 5
21 Dec 2022 Submitted Manuscript version 5
3 Jan 2023 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 6
3 Jan 2023 Submitted Manuscript version 6
5 Jan 2023 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 7
5 Jan 2023 Submitted Manuscript version 7
2 May 2023 Reviewed Reviewer Report
9 May 2023 Reviewed Reviewer Report
12 Jun 2023 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 8
12 Jun 2023 Submitted Manuscript version 8
13 Jun 2023 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 9
13 Jun 2023 Submitted Manuscript version 9
14 Jun 2023 Author responded Author comments - Dr.Vineeta Shobha
Resubmission - Version 10
14 Jun 2023 Submitted Manuscript version 10
Publishing
10 Jul 2023 Editorially accepted
26 Jul 2023 Article published 10.1186/s41927-023-00345-8

You can find further information about peer review here.

Back to article page